Mutual Fund Ownership
Ownership as on: Sun, 21 Apr, 2024

DSP Healthcare Fund Regular Growth

NA
Equity
Amount Invested (Cr.)195.92
% of AUM8.33%

ITI Pharma and Healthcare Fund Regular Growth

NA
Equity
Amount Invested (Cr.)7.32
% of AUM4.56%

Samco ELSS Tax Saver Fund Regular Growth

NA
Equity
Amount Invested (Cr.)4.14
% of AUM4.41%

UTI Healthcare Fund Regular Plan Growth

NA
Equity
Amount Invested (Cr.)29.80
% of AUM3.15%

DSP Focus Fund Growth

2/5
Equity
Amount Invested (Cr.)63.68
% of AUM2.91%

FAQs about Suven Pharmaceuticals share price

Suven Pharmaceuticals is trading at 645.75 as on Fri Apr 19 2024 09:59:15. This is -0.68% lower as compared to its previous closing price of 650.20.

The market capitalization of Suven Pharmaceuticals is 16438.53 Cr as on Fri Apr 19 2024 09:59:15.

The average broker rating on Suven Pharmaceuticals is Strong Buy. The breakup of analyst rating is given below -

  • 1 analysts have given a strong buy rating
  • 0 analysts have given a buy rating
  • 0 analysts have given a hold rating
  • 0 analysts have given a sell rating
  • 0 analysts have given a strong sell rating

The 52 wk high for Suven Pharmaceuticals is 767.00 whereas the 52 wk low is 427.05

Suven Pharmaceuticals can be analyzed on the following key metrics -

  • TTM P/E: 49.59
  • Sector P/E: 30.14
  • Dividend Yield: 0.00%
  • D/E ratio: -

Suven Pharmaceuticals reported a net profit of 411.29 Cr in 2023.

Recommended For You
Trending Stocks
7,107.00+217.75(3.16%)
2,082.90+58.75(2.90%)
1,531.30+36.70(2.46%)
1,450.00-17.65 (-1.20%)
2,437.10-25.65 (-1.04%)
HomeMarketsPremiumFor youGet App